ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013

New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation

July 11, 1980

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

Lung Cancer Studies Described by DCT, VA

May 9, 1975

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985